Dr. Sheng's research focuses on addressing the needs of breast cancer patients, especially improving quality of life and addressing comorbidity, promptly detecting sequela of endocrine therapy, determining the optimal population for and timing of survivorship care and furthering obesity management in breast cancer patients.
Sheng JY, Blackford AL, Bardia A, Venkat R, Rosson G, Giles J, Hayes DF, Jeter SC, Zhang Z, Hayden J, Nguyen A, Storniolo AM, Tarpinian K, Henry NL, Stearns V. Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy. Breast Cancer Res Treat. 2019 Aug; 176(3): 617-624. PMID: 31079282.
Skuli SJ, Sheng JY, Bantug ET, Zafman N, Riley C, Ruck JM, Smith KC, Snyder CF, Smith KL, Stearns V, Wolff AC. Survivorship care visits in a high-risk population of breast cancer survivors. Breast Cancer Res Treat. 2019 Feb; 173(3):701-708. 2019 Feb; 173(3): 701-708. PubMed PMID: 30406364.
Sheng JY, Sharma D, Jerome GJ, Santa-Maria CA. Obese Breast Cancer Patients and Survivors: Management Consideration. Oncology. 2018; 32 (8): 410-7. PMID: 30153321
Sheng JY, Santa-Maria CA, Mangini N, Norman H, Couzi R, Nunes R, Wilkinson M, Visvanathan K, Connolly RM, Roussos-Torres ET, Fetting JH, Armstrong DK, Tao JJ, Jacobs L, Wright JL, Thorner ED, Hodgdon C, Horn S, Wolff AC, Stearns V, and Smith KL. Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach. JCO Oncology Practice. 2020 Jun 30; OP2000364. PMID: 32603252.